Cargando…
Emerging Roles of Aryl Hydrocarbon Receptors in the Altered Clearance of Drugs during Chronic Kidney Disease
Chronic kidney disease (CKD) is a major public health problem, since 300,000,000 people in the world display a glomerular filtration rate (GFR) below 60 mL/min/1.73m(2). Patients with CKD have high rates of complications and comorbidities. Thus, they require the prescription of numerous medications,...
Autores principales: | Santana Machado, Tacy, Cerini, Claire, Burtey, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521271/ https://www.ncbi.nlm.nih.gov/pubmed/30959953 http://dx.doi.org/10.3390/toxins11040209 |
Ejemplares similares
-
The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
por: Sallée, Marion, et al.
Publicado: (2014) -
The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
por: Mo, Yenan, et al.
Publicado: (2020) -
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
por: Curran, Colleen S., et al.
Publicado: (2022) -
Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells
por: Lano, Guillaume, et al.
Publicado: (2020) -
Effect of Dialysis on Aryl Hydrocarbon Receptor Transactivating Activity in Patients with Chronic Kidney Disease
por: Kim, Jin Taek, et al.
Publicado: (2020)